SEC Filing Details

Document Details

Filing Date
Nov 14, 1995
Document Date
Nov 14, 1995
Form Description
Delaying amendment
Filing Group
Registration Statements
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline